시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 커넥티드 약물전달 디바이스 시장 - 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 용도별, 최종 사용자별, 지역별 산업 예측(2024-2031년)
Connected Drug Delivery Devices Market Size, Share, Growth Analysis, By Product Type (Connected Inhalers, Metered Dose Inhalers (MDIs)), By Technology (Bluetooth, Wi-Fi), By Application, By End-User, By Region - Industry Forecast 2024-2031
상품코드 : 1619107
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,665,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,967,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,268,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

커넥티드 약물전달 디바이스 세계 시장 규모는 2022년 3억 4,790만 달러로 평가되었으며, 2023년 4억 3,348만 달러에서 2031년에는 25억 1,835만 달러로 성장해 예측 기간 중(2024-2031년)의 CAGR은 24.6%로 성장할 전망입니다.

세계의 커넥티드 약물전달 디바이스 시장은 디지털 헬스 솔루션의 보급과 개별화 헬스케어 수요 증가에 추진되어 큰 성장을 이루려고 하고 있습니다. 데이터 추적, 알림, 알림을 제공하고 약물 관리 및 환자 결과를 개선합니다. 진보된 기술은 약물전달 시스템을 변화시키고 환자 참여를 강화하고 원격 모니터링을 용이하게 합니다. 더 나은 환자 경험과 결과를 위해 기술 통합을 점점 받아들이게 될 건강 관리 제공의 변화를 반영합니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

커넥티드 약물전달 디바이스 시장 규모 : 제품 유형별 및 CAGR(2024-2031년)

커넥티드 약물전달 디바이스 시장 규모 : 기술별 및 CAGR(2024-2031년)

커넥티드 약물전달 디바이스 시장 규모 : 용도별 및 CAGR(2024-2031년)

커넥티드 약물전달 디바이스 시장 규모 : 최종 사용자별 및 CAGR(2024-2031년)

커넥티드 약물전달 디바이스 시장 규모 및 CAGR(2024-2031년)

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Global Connected Drug Delivery Devices Market size was valued at USD 347.9 million in 2022 and is poised to grow from USD 433.48 million in 2023 to USD 2518.35 million by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global connected drug delivery devices market is poised for significant growth, fueled by the rising adoption of digital health solutions and the demand for personalized healthcare. These innovative devices provide real-time data tracking, reminders, and notifications for patients and caregivers, improving medication management and patient outcomes. Advanced technologies like IoT, AI, and cloud computing are transforming drug delivery systems, fostering enhanced patient engagement and facilitating remote monitoring. As healthcare systems prioritize digital transformation and patient-centric approaches, the market is set to expand substantially, reflecting a shifting landscape in healthcare delivery that increasingly embraces technological integration for better patient experiences and outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Connected Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Connected Drug Delivery Devices Market Segmental Analysis

Global Connected Drug Delivery Devices Market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into connected inhalers, connected injection devices and connected monitoring devices. Based on technology, the market is segmented into bluetooth, wi-fi, near field communication (NFC) and others. Based on application, the market is segmented into diabetes, asthma & COPD, cardiovascular diseases and other. Based on end-user, the market is segmented into hospitals, homecare settings and clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Connected Drug Delivery Devices Market

A significant driver for the global connected drug delivery devices market is the rising demand for personalized and interconnected healthcare solutions. These innovative devices provide numerous advantages, including remote patient tracking, real-time data collection, and enhanced medication adherence. By allowing healthcare professionals to monitor patient health continuously, they can adjust treatment plans accordingly and deliver tailored care. Furthermore, the incorporation of connected technologies into drug delivery systems fosters greater patient engagement and leads to improved treatment outcomes. The escalating incidence of chronic diseases and the increasing need for sophisticated drug delivery mechanisms also play essential roles in propelling the growth of this market.

Restraints in the Global Connected Drug Delivery Devices Market

A major constraint facing the global connected drug delivery devices market is the substantial cost linked to these advanced technologies. These devices incorporate intricate components such as wireless connectivity and sophisticated data management systems, which collectively contribute to elevated pricing. Such financial implications can hinder widespread acceptance, especially in low-resource environments and developing countries, where budgetary limitations are critical. This cost-related barrier restricts the availability and use of connected drug delivery devices among various patient demographics and healthcare frameworks. To facilitate broader market growth and enhance adoption rates, it is crucial to tackle affordability issues effectively.

Market Trends of the Global Connected Drug Delivery Devices Market

The global connected drug delivery devices market is witnessing a significant trend towards the adoption of smart inhalers and connected devices, especially for respiratory therapies. These advanced devices leverage sensors, wireless connectivity, and mobile applications to facilitate comprehensive tracking of medication usage, dosage accuracy, and patient adherence. The incorporation of digital technologies not only enables real-time data collection and remote monitoring but also supports personalized treatment plans tailored to individual patient needs. This trend fosters enhanced patient engagement and empowerment, as users gain valuable insights and feedback on their medication habits, ultimately driving improved health outcomes and ensuring greater adherence to treatment protocols.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Connected Drug Delivery Devices Market Size by Product Type & CAGR (2024-2031)

Global Connected Drug Delivery Devices Market Size by Technology & CAGR (2024-2031)

Global Connected Drug Delivery Devices Market Size by Application & CAGR (2024-2031)

Global Connected Drug Delivery Devices Market Size by End-User & CAGR (2024-2031)

Global Connected Drug Delivery Devices Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기